Concepts (320)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fluid Therapy | 14 | 2021 | 593 | 2.100 |
Why?
|
| Cholera | 27 | 2021 | 785 | 1.350 |
Why?
|
| Dehydration | 10 | 2021 | 232 | 1.340 |
Why?
|
| Ethics, Medical | 4 | 2021 | 792 | 1.260 |
Why?
|
| Rehydration Solutions | 4 | 2021 | 47 | 1.080 |
Why?
|
| Diarrhea | 22 | 2018 | 1348 | 0.930 |
Why?
|
| Rabies Vaccines | 1 | 2019 | 31 | 0.680 |
Why?
|
| Rabies | 1 | 2019 | 61 | 0.660 |
Why?
|
| Placebos | 4 | 2021 | 1674 | 0.570 |
Why?
|
| India | 12 | 2019 | 2200 | 0.560 |
Why?
|
| Guidelines as Topic | 3 | 2021 | 1404 | 0.550 |
Why?
|
| Human Experimentation | 3 | 2006 | 127 | 0.490 |
Why?
|
| Floods | 1 | 2013 | 42 | 0.460 |
Why?
|
| Poliomyelitis | 1 | 2014 | 103 | 0.450 |
Why?
|
| Electrolytes | 6 | 2006 | 282 | 0.430 |
Why?
|
| Abortion, Induced | 1 | 2018 | 458 | 0.410 |
Why?
|
| Cyclonic Storms | 1 | 2013 | 119 | 0.410 |
Why?
|
| Ethics Committees, Research | 1 | 2013 | 194 | 0.400 |
Why?
|
| Vibrio cholerae O1 | 1 | 2014 | 242 | 0.400 |
Why?
|
| Immunization | 2 | 2014 | 1255 | 0.400 |
Why?
|
| Child Mortality | 1 | 2013 | 198 | 0.390 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2018 | 1320 | 0.380 |
Why?
|
| Counseling | 1 | 2018 | 1523 | 0.360 |
Why?
|
| Child Welfare | 1 | 2013 | 523 | 0.340 |
Why?
|
| Medicine, Traditional | 2 | 2008 | 91 | 0.340 |
Why?
|
| Ethics Committees | 1 | 2008 | 54 | 0.330 |
Why?
|
| Preventive Health Services | 1 | 2013 | 575 | 0.320 |
Why?
|
| Health Personnel | 1 | 2022 | 3217 | 0.320 |
Why?
|
| Microbial Sensitivity Tests | 3 | 2013 | 1870 | 0.310 |
Why?
|
| Disasters | 1 | 2013 | 511 | 0.300 |
Why?
|
| Bicarbonates | 12 | 2004 | 312 | 0.290 |
Why?
|
| Ethics, Research | 2 | 2006 | 191 | 0.290 |
Why?
|
| Directly Observed Therapy | 1 | 2007 | 137 | 0.280 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2018 | 2027 | 0.280 |
Why?
|
| Pandemics | 3 | 2022 | 8385 | 0.270 |
Why?
|
| Glucose | 11 | 2006 | 4398 | 0.270 |
Why?
|
| Health Services Accessibility | 3 | 2018 | 5136 | 0.260 |
Why?
|
| Peer Review, Research | 1 | 2008 | 329 | 0.260 |
Why?
|
| Health Policy | 3 | 2014 | 2662 | 0.260 |
Why?
|
| Biomedical Research | 1 | 2021 | 3308 | 0.260 |
Why?
|
| Tuberculosis, Multidrug-Resistant | 1 | 2013 | 912 | 0.260 |
Why?
|
| Epidemics | 2 | 2023 | 523 | 0.250 |
Why?
|
| Healthcare Disparities | 1 | 2020 | 3155 | 0.250 |
Why?
|
| Bangladesh | 6 | 2014 | 687 | 0.250 |
Why?
|
| Potassium Chloride | 3 | 2004 | 237 | 0.240 |
Why?
|
| International Cooperation | 3 | 2021 | 1419 | 0.240 |
Why?
|
| Complementary Therapies | 1 | 2008 | 485 | 0.240 |
Why?
|
| Community-Institutional Relations | 1 | 2006 | 204 | 0.240 |
Why?
|
| Disease Outbreaks | 1 | 2014 | 1771 | 0.240 |
Why?
|
| Sodium Chloride | 5 | 2004 | 625 | 0.230 |
Why?
|
| Staff Development | 1 | 2005 | 223 | 0.220 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3134 | 0.210 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3241 | 0.200 |
Why?
|
| Pneumonia | 1 | 2013 | 2133 | 0.200 |
Why?
|
| Ethics | 1 | 2001 | 94 | 0.200 |
Why?
|
| History, 20th Century | 4 | 2021 | 2736 | 0.200 |
Why?
|
| Nuclear Weapons | 1 | 2021 | 13 | 0.190 |
Why?
|
| Nuclear Warfare | 1 | 2021 | 31 | 0.190 |
Why?
|
| World Health Organization | 4 | 2023 | 1317 | 0.190 |
Why?
|
| Diarrhea, Infantile | 6 | 1997 | 109 | 0.190 |
Why?
|
| Amino Acids | 1 | 2006 | 1733 | 0.170 |
Why?
|
| Administration, Oral | 15 | 2021 | 3912 | 0.170 |
Why?
|
| Antitubercular Agents | 1 | 2007 | 1320 | 0.160 |
Why?
|
| El Salvador | 1 | 2018 | 36 | 0.160 |
Why?
|
| Horses | 1 | 2019 | 304 | 0.160 |
Why?
|
| Criminal Law | 1 | 2018 | 96 | 0.150 |
Why?
|
| Humans | 72 | 2023 | 743811 | 0.150 |
Why?
|
| Moral Obligations | 1 | 2018 | 96 | 0.150 |
Why?
|
| Poverty | 2 | 2020 | 2660 | 0.150 |
Why?
|
| Rotavirus Vaccines | 1 | 1997 | 61 | 0.150 |
Why?
|
| Rotavirus Infections | 1 | 1997 | 86 | 0.140 |
Why?
|
| Hyponatremia | 1 | 1999 | 297 | 0.140 |
Why?
|
| Pakistan | 3 | 2014 | 295 | 0.140 |
Why?
|
| Patient Compliance | 1 | 2007 | 2683 | 0.140 |
Why?
|
| Clinical Trials as Topic | 6 | 2008 | 7908 | 0.130 |
Why?
|
| Developing Countries | 7 | 2006 | 2815 | 0.130 |
Why?
|
| Immunoglobulins | 1 | 2019 | 881 | 0.130 |
Why?
|
| Cameroon | 1 | 2014 | 71 | 0.120 |
Why?
|
| Syria | 1 | 2014 | 76 | 0.120 |
Why?
|
| Dogs | 1 | 2019 | 3911 | 0.120 |
Why?
|
| Tuberculosis | 1 | 2007 | 1914 | 0.120 |
Why?
|
| Physician's Role | 1 | 2021 | 942 | 0.120 |
Why?
|
| Government Regulation | 1 | 2018 | 522 | 0.110 |
Why?
|
| Publishing | 1 | 2021 | 833 | 0.110 |
Why?
|
| Water-Electrolyte Balance | 9 | 2002 | 346 | 0.110 |
Why?
|
| Antibiotics, Antitubercular | 1 | 2013 | 103 | 0.110 |
Why?
|
| Income | 1 | 2022 | 1913 | 0.110 |
Why?
|
| Communicable Disease Control | 1 | 2000 | 856 | 0.110 |
Why?
|
| Viral Vaccines | 1 | 1997 | 636 | 0.100 |
Why?
|
| Rifampin | 1 | 2013 | 315 | 0.100 |
Why?
|
| Leprosy | 1 | 1991 | 124 | 0.100 |
Why?
|
| Health Education | 2 | 1997 | 1056 | 0.090 |
Why?
|
| Professional Role | 1 | 2013 | 306 | 0.090 |
Why?
|
| Public Health | 1 | 2023 | 2603 | 0.090 |
Why?
|
| Quality of Health Care | 1 | 2005 | 4370 | 0.090 |
Why?
|
| Population Surveillance | 1 | 2000 | 2614 | 0.080 |
Why?
|
| Pediatrics | 2 | 2021 | 3474 | 0.080 |
Why?
|
| Family Practice | 1 | 1991 | 516 | 0.080 |
Why?
|
| Medicine, Ayurvedic | 1 | 2008 | 37 | 0.080 |
Why?
|
| Travel | 1 | 2014 | 788 | 0.080 |
Why?
|
| History, 21st Century | 1 | 2014 | 1532 | 0.080 |
Why?
|
| Research Design | 2 | 2019 | 5983 | 0.070 |
Why?
|
| Informed Consent | 2 | 2006 | 995 | 0.070 |
Why?
|
| Researcher-Subject Relations | 1 | 2006 | 16 | 0.070 |
Why?
|
| Private Practice | 1 | 2007 | 153 | 0.070 |
Why?
|
| Circumcision, Male | 1 | 2007 | 150 | 0.070 |
Why?
|
| Vibrio cholerae | 4 | 1976 | 807 | 0.060 |
Why?
|
| National Health Programs | 2 | 2007 | 445 | 0.060 |
Why?
|
| Child | 21 | 2021 | 77637 | 0.060 |
Why?
|
| Osmolar Concentration | 2 | 2004 | 683 | 0.060 |
Why?
|
| Physician-Patient Relations | 1 | 2018 | 3229 | 0.060 |
Why?
|
| Endemic Diseases | 1 | 2005 | 182 | 0.060 |
Why?
|
| Attitude of Health Personnel | 3 | 2007 | 3839 | 0.060 |
Why?
|
| Safety | 1 | 2008 | 1184 | 0.060 |
Why?
|
| Developed Countries | 1 | 2005 | 437 | 0.050 |
Why?
|
| Cholera Vaccines | 2 | 1976 | 268 | 0.050 |
Why?
|
| Health Priorities | 1 | 2005 | 380 | 0.050 |
Why?
|
| Certification | 1 | 2005 | 423 | 0.050 |
Why?
|
| Injections, Intravenous | 3 | 2002 | 1422 | 0.050 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2002 | 277 | 0.050 |
Why?
|
| Confidentiality | 1 | 2006 | 613 | 0.050 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2007 | 623 | 0.050 |
Why?
|
| Sodium | 6 | 1977 | 1622 | 0.050 |
Why?
|
| Tetracycline | 4 | 1985 | 214 | 0.050 |
Why?
|
| Organizational Objectives | 1 | 2002 | 438 | 0.050 |
Why?
|
| Acidosis | 3 | 1973 | 271 | 0.040 |
Why?
|
| Solutions | 4 | 1982 | 426 | 0.040 |
Why?
|
| Plague | 1 | 2000 | 22 | 0.040 |
Why?
|
| Antitoxins | 3 | 1974 | 81 | 0.040 |
Why?
|
| Interviews as Topic | 1 | 2007 | 2538 | 0.040 |
Why?
|
| Disease Notification | 1 | 2000 | 98 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 14714 | 0.040 |
Why?
|
| Education | 1 | 2001 | 543 | 0.040 |
Why?
|
| Research Personnel | 1 | 2003 | 573 | 0.040 |
Why?
|
| Health Services Needs and Demand | 1 | 2006 | 1411 | 0.040 |
Why?
|
| Acrodermatitis | 2 | 1984 | 18 | 0.040 |
Why?
|
| Internationality | 1 | 2003 | 1002 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 1 | 2002 | 1676 | 0.040 |
Why?
|
| Peru | 1 | 2000 | 882 | 0.040 |
Why?
|
| Rotavirus | 1 | 1997 | 109 | 0.040 |
Why?
|
| Prevalence | 1 | 2013 | 15211 | 0.040 |
Why?
|
| Animals | 3 | 2019 | 168660 | 0.030 |
Why?
|
| Vaccines | 1 | 2005 | 823 | 0.030 |
Why?
|
| Pregnancy | 1 | 2018 | 29140 | 0.030 |
Why?
|
| AIDS Vaccines | 1 | 2003 | 938 | 0.030 |
Why?
|
| Potassium | 5 | 1973 | 1336 | 0.030 |
Why?
|
| Gastric Juice | 2 | 1974 | 63 | 0.030 |
Why?
|
| Clinical Competence | 2 | 2005 | 4687 | 0.030 |
Why?
|
| Sulfamethoxazole | 1 | 1973 | 53 | 0.030 |
Why?
|
| Trimethoprim | 1 | 1973 | 91 | 0.030 |
Why?
|
| Child, Preschool | 16 | 1997 | 40964 | 0.030 |
Why?
|
| Leadership | 1 | 2002 | 1357 | 0.030 |
Why?
|
| United States | 2 | 2021 | 69859 | 0.030 |
Why?
|
| Glycosides | 1 | 1973 | 107 | 0.030 |
Why?
|
| Primary Health Care | 1 | 1988 | 4556 | 0.030 |
Why?
|
| Jejunum | 2 | 1975 | 480 | 0.030 |
Why?
|
| Communication | 1 | 2006 | 3748 | 0.030 |
Why?
|
| Self Care | 1 | 1997 | 786 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 7 | 1974 | 2556 | 0.020 |
Why?
|
| Leucine | 1 | 1973 | 559 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2001 | 2265 | 0.020 |
Why?
|
| Feces | 10 | 1976 | 1397 | 0.020 |
Why?
|
| Citrates | 1 | 1970 | 131 | 0.020 |
Why?
|
| Dysentery, Bacillary | 2 | 1989 | 75 | 0.020 |
Why?
|
| Virilism | 1 | 1969 | 31 | 0.020 |
Why?
|
| Infusions, Parenteral | 5 | 1973 | 419 | 0.020 |
Why?
|
| Education, Medical | 1 | 2001 | 1722 | 0.020 |
Why?
|
| Female | 18 | 2018 | 380020 | 0.020 |
Why?
|
| Indians, North American | 5 | 1975 | 355 | 0.020 |
Why?
|
| Fatty Acids, Essential | 1 | 1969 | 95 | 0.020 |
Why?
|
| Physicians | 1 | 2007 | 4569 | 0.020 |
Why?
|
| Water Supply | 2 | 1989 | 214 | 0.020 |
Why?
|
| Hepatitis A | 1 | 1989 | 133 | 0.020 |
Why?
|
| Lysine | 1 | 1973 | 1007 | 0.020 |
Why?
|
| Infant | 10 | 1997 | 35122 | 0.020 |
Why?
|
| Acetates | 1 | 1969 | 310 | 0.020 |
Why?
|
| Curriculum | 1 | 2001 | 3603 | 0.020 |
Why?
|
| United Nations | 1 | 1988 | 165 | 0.020 |
Why?
|
| Rural Health | 3 | 1997 | 305 | 0.020 |
Why?
|
| Ethiopia | 1 | 1988 | 495 | 0.020 |
Why?
|
| Educational Measurement | 1 | 1993 | 1210 | 0.020 |
Why?
|
| Chlorides | 3 | 1977 | 667 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2003 | 9944 | 0.020 |
Why?
|
| Enteral Nutrition | 2 | 1971 | 767 | 0.020 |
Why?
|
| Indonesia | 1 | 1985 | 119 | 0.020 |
Why?
|
| Adult | 20 | 2007 | 213889 | 0.020 |
Why?
|
| Ovary | 1 | 1969 | 980 | 0.020 |
Why?
|
| Gastric Acidity Determination | 3 | 1974 | 62 | 0.020 |
Why?
|
| Pyridones | 1 | 1969 | 711 | 0.020 |
Why?
|
| Aniline Compounds | 1 | 1969 | 986 | 0.020 |
Why?
|
| Health Care Costs | 1 | 1997 | 3207 | 0.010 |
Why?
|
| Male | 23 | 2007 | 349776 | 0.010 |
Why?
|
| Pain Insensitivity, Congenital | 1 | 1983 | 9 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2001 | 7270 | 0.010 |
Why?
|
| Picolinic Acids | 1 | 1984 | 52 | 0.010 |
Why?
|
| Control Groups | 1 | 2003 | 105 | 0.010 |
Why?
|
| Governing Board | 1 | 2002 | 53 | 0.010 |
Why?
|
| Powders | 1 | 1982 | 80 | 0.010 |
Why?
|
| Anticonvulsants | 2 | 1969 | 1910 | 0.010 |
Why?
|
| Tryptophan | 1 | 1984 | 478 | 0.010 |
Why?
|
| Administrative Personnel | 1 | 2002 | 187 | 0.010 |
Why?
|
| Intubation, Gastrointestinal | 3 | 1971 | 153 | 0.010 |
Why?
|
| Fatty Acids | 1 | 1969 | 1809 | 0.010 |
Why?
|
| Policy Making | 1 | 2005 | 554 | 0.010 |
Why?
|
| Health Services Research | 1 | 1988 | 1836 | 0.010 |
Why?
|
| Gastrointestinal Diseases | 1 | 1969 | 1171 | 0.010 |
Why?
|
| Health Services | 1 | 1985 | 758 | 0.010 |
Why?
|
| Drug Combinations | 2 | 1977 | 1958 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 1985 | 1680 | 0.010 |
Why?
|
| Intestinal Diseases | 1 | 1984 | 531 | 0.010 |
Why?
|
| Antibodies, Bacterial | 2 | 1974 | 1470 | 0.010 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 1979 | 114 | 0.010 |
Why?
|
| Kidney | 1 | 1973 | 7185 | 0.010 |
Why?
|
| Vibrio | 3 | 1971 | 41 | 0.010 |
Why?
|
| Infant Food | 1 | 1997 | 141 | 0.010 |
Why?
|
| HIV Infections | 1 | 2003 | 16715 | 0.010 |
Why?
|
| Toxoids | 1 | 1974 | 12 | 0.010 |
Why?
|
| Hemagglutination Tests | 1 | 1974 | 75 | 0.010 |
Why?
|
| Colistin | 1 | 1975 | 47 | 0.010 |
Why?
|
| Vaccines, Attenuated | 1 | 1976 | 342 | 0.010 |
Why?
|
| Carbon Isotopes | 2 | 1973 | 468 | 0.010 |
Why?
|
| Private Sector | 1 | 1997 | 393 | 0.010 |
Why?
|
| Drug Resistance, Microbial | 2 | 1974 | 860 | 0.010 |
Why?
|
| Consensus | 1 | 2003 | 2954 | 0.010 |
Why?
|
| Immunization Schedule | 1 | 1974 | 221 | 0.010 |
Why?
|
| Data Collection | 1 | 2003 | 3339 | 0.010 |
Why?
|
| Protein Hydrolysates | 1 | 1972 | 7 | 0.010 |
Why?
|
| Histological Techniques | 1 | 1973 | 198 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 1973 | 349 | 0.010 |
Why?
|
| Health Expenditures | 1 | 1985 | 2348 | 0.010 |
Why?
|
| Aminoglutethimide | 2 | 1969 | 15 | 0.010 |
Why?
|
| Risk Factors | 1 | 1999 | 72252 | 0.010 |
Why?
|
| Neutralization Tests | 1 | 1974 | 757 | 0.010 |
Why?
|
| Pituitary-Adrenal Function Tests | 2 | 1969 | 31 | 0.010 |
Why?
|
| Stereoisomerism | 1 | 1973 | 624 | 0.010 |
Why?
|
| Hypokalemia | 1 | 1973 | 153 | 0.010 |
Why?
|
| Adolescent | 10 | 1997 | 85729 | 0.010 |
Why?
|
| Injections | 1 | 1974 | 839 | 0.010 |
Why?
|
| Achlorhydria | 1 | 1970 | 11 | 0.010 |
Why?
|
| Escherichia coli Infections | 1 | 1975 | 532 | 0.010 |
Why?
|
| Adrenal Glands | 2 | 1975 | 547 | 0.010 |
Why?
|
| Specific Gravity | 1 | 1970 | 20 | 0.010 |
Why?
|
| Blood Proteins | 2 | 1973 | 1125 | 0.010 |
Why?
|
| Extracellular Space | 1 | 1973 | 595 | 0.010 |
Why?
|
| Methods | 1 | 1971 | 1128 | 0.010 |
Why?
|
| Creatinine | 2 | 1973 | 1918 | 0.010 |
Why?
|
| 17-Ketosteroids | 1 | 1969 | 39 | 0.010 |
Why?
|
| 17-Hydroxycorticosteroids | 1 | 1969 | 40 | 0.010 |
Why?
|
| Iodoquinol | 1 | 1969 | 1 | 0.010 |
Why?
|
| Metyrapone | 1 | 1969 | 23 | 0.010 |
Why?
|
| Shigella | 3 | 1975 | 74 | 0.010 |
Why?
|
| Intestinal Absorption | 1 | 1970 | 420 | 0.010 |
Why?
|
| Hematocrit | 1 | 1970 | 636 | 0.010 |
Why?
|
| Histamine | 1 | 1970 | 507 | 0.010 |
Why?
|
| Thyroid Function Tests | 1 | 1969 | 286 | 0.010 |
Why?
|
| Acute Disease | 3 | 1975 | 7150 | 0.000 |
Why?
|
| Program Evaluation | 1 | 1997 | 2483 | 0.000 |
Why?
|
| Bacteriophages | 1 | 1971 | 356 | 0.000 |
Why?
|
| Hypertrophy | 1 | 1969 | 569 | 0.000 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1969 | 648 | 0.000 |
Why?
|
| Glycine | 1 | 1970 | 670 | 0.000 |
Why?
|
| Anti-HIV Agents | 1 | 2003 | 4255 | 0.000 |
Why?
|
| Endocrine System Diseases | 1 | 1969 | 247 | 0.000 |
Why?
|
| Mothers | 1 | 1997 | 2166 | 0.000 |
Why?
|
| Stomach | 1 | 1970 | 697 | 0.000 |
Why?
|
| Cushing Syndrome | 1 | 1966 | 249 | 0.000 |
Why?
|
| Arizona | 2 | 1975 | 108 | 0.000 |
Why?
|
| Milk, Human | 1 | 1969 | 490 | 0.000 |
Why?
|
| Growth Disorders | 1 | 1969 | 645 | 0.000 |
Why?
|
| Water | 1 | 1970 | 1394 | 0.000 |
Why?
|
| Salmonella | 2 | 1975 | 129 | 0.000 |
Why?
|
| Epidemiologic Methods | 1 | 1989 | 1364 | 0.000 |
Why?
|
| Sural Nerve | 1 | 1983 | 106 | 0.000 |
Why?
|
| Kynurenine | 1 | 1984 | 139 | 0.000 |
Why?
|
| China | 1 | 1989 | 2243 | 0.000 |
Why?
|
| Dysautonomia, Familial | 1 | 1983 | 95 | 0.000 |
Why?
|
| Vaccination | 1 | 1974 | 3275 | 0.000 |
Why?
|
| Water Microbiology | 2 | 1974 | 117 | 0.000 |
Why?
|
| Thyroid Gland | 1 | 1969 | 1173 | 0.000 |
Why?
|
| Escherichia coli | 4 | 1975 | 4216 | 0.000 |
Why?
|
| Muscle Hypotonia | 1 | 1983 | 165 | 0.000 |
Why?
|
| Time Factors | 3 | 1973 | 40038 | 0.000 |
Why?
|
| Intestinal Mucosa | 1 | 1973 | 3038 | 0.000 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1966 | 740 | 0.000 |
Why?
|
| Biopsy | 1 | 1973 | 6750 | 0.000 |
Why?
|
| Zinc | 1 | 1984 | 683 | 0.000 |
Why?
|
| Facial Expression | 1 | 1983 | 508 | 0.000 |
Why?
|
| Body Weight | 3 | 1975 | 4670 | 0.000 |
Why?
|
| Syndrome | 1 | 1983 | 3249 | 0.000 |
Why?
|
| Cost-Benefit Analysis | 1 | 1989 | 5388 | 0.000 |
Why?
|
| United States Public Health Service | 1 | 1974 | 31 | 0.000 |
Why?
|
| Hypotonic Solutions | 1 | 1973 | 49 | 0.000 |
Why?
|
| Sanitation | 1 | 1974 | 93 | 0.000 |
Why?
|
| Drug Evaluation | 1 | 1975 | 647 | 0.000 |
Why?
|
| Enterotoxins | 1 | 1975 | 368 | 0.000 |
Why?
|
| Shigella flexneri | 1 | 1974 | 132 | 0.000 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 1975 | 303 | 0.000 |
Why?
|
| Weather | 1 | 1974 | 228 | 0.000 |
Why?
|
| Ileum | 1 | 1975 | 565 | 0.000 |
Why?
|
| Infant Nutrition Disorders | 1 | 1972 | 73 | 0.000 |
Why?
|
| Biological Assay | 1 | 1975 | 650 | 0.000 |
Why?
|
| Parasites | 1 | 1974 | 163 | 0.000 |
Why?
|
| Rectum | 1 | 1974 | 904 | 0.000 |
Why?
|
| Middle Aged | 4 | 1989 | 213241 | 0.000 |
Why?
|
| Rabbits | 1 | 1975 | 4894 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1989 | 25609 | 0.000 |
Why?
|
| Seasons | 1 | 1974 | 1493 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1983 | 12954 | 0.000 |
Why?
|
| Temperature | 1 | 1974 | 2202 | 0.000 |
Why?
|
| Shock | 1 | 1970 | 318 | 0.000 |
Why?
|
| Dichlorodiphenyldichloroethane | 1 | 1966 | 7 | 0.000 |
Why?
|
| Drug Synergism | 1 | 1970 | 1794 | 0.000 |
Why?
|
| Age Factors | 2 | 1975 | 18355 | 0.000 |
Why?
|
| Parenteral Nutrition | 1 | 1968 | 650 | 0.000 |
Why?
|
| Hydrocortisone | 1 | 1966 | 1826 | 0.000 |
Why?
|
| Models, Biological | 1 | 1975 | 9582 | 0.000 |
Why?
|
| Neoplasm Metastasis | 1 | 1966 | 4848 | 0.000 |
Why?
|
| Hospitalization | 1 | 1974 | 10259 | 0.000 |
Why?
|
| Mice | 1 | 1975 | 81154 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 1966 | 13691 | 0.000 |
Why?
|
Concepts
(320)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(7)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_